Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:cholic_acid
|
| gptkbp:approvalYear |
2015
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
A05AA03
|
| gptkbp:chemicalFormula |
C24H40O5
|
| gptkbp:contraindication |
obstruction of the biliary tract
|
| gptkbp:form |
capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cholbam
|
| gptkbp:indication |
treatment of bile acid synthesis disorders due to single enzyme defects
adjunctive treatment of peroxisomal disorders (including Zellweger spectrum disorders) |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Retrophin
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:PubChem_CID |
DB09135
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
gastrointestinal symptoms |
| gptkbp:UNII |
G79R3F8A4W
|
| gptkbp:usedFor |
bile acid synthesis disorders
peroxisomal disorders |
| gptkbp:bfsParent |
gptkb:Retrophin
gptkb:Travere_Therapeutics |
| gptkbp:bfsLayer |
7
|